Nasal Polyp Surgery Questions & Answers

1. del Toro E, Portela J. Nasal Polyps. StatPearls. 2023 Jan. [QxMD MEDLINE Link]. [Full Text].

2. Deal RT, Kountakis SE. Significance of nasal polyps in chronic rhinosinusitis: symptoms and surgical outcomes. Laryngoscope. 2004 Nov. 114(11):1932-5. [QxMD MEDLINE Link].

3. Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl. 2007. (20):1-136. [QxMD MEDLINE Link].

4. Novelli F, Bacci E, Latorre M, et al. Comorbidities are associated with different features of severe asthma. Clin Mol Allergy. 2018. 16:25. [QxMD MEDLINE Link]. [Full Text].

5. US Food and Drug Administration. FDA approves first treatment for chronic rhinosinusitis with nasal polyps. FDA. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-chronic-rhinosinusitis-nasal-polyps. June 26, 2019; Accessed: June 21, 2021.

6. Palmer JN, Messina JC, Biletch R, Grosel K, Mahmoud RA. A cross-sectional, population-based survey of U.S. adults with symptoms of chronic rhinosinusitis. Allergy Asthma Proc. 2019 Jan 14. 40 (1):48-56. [QxMD MEDLINE Link].

7. De Corso E, Lucidi D, Battista M, et al. Prognostic value of nasal cytology and clinical factors in nasal polyps development in patients at risk: can the beginning predict the end?. Int Forum Allergy Rhinol. 2017 Jun 30. [QxMD MEDLINE Link].

8. Cornet ME, Kostamo K, Rinia AB, et al. Novel roles for nasal epithelium in the pathogenesis of chronic rhinosinusitis with nasal polyps. Rhinology. 2018 Dec 1. [QxMD MEDLINE Link].

9. Tang J, Liu S, Zhang L, Chen W, Shi S, Yu Q, et al. Correlation analysis of prognostic and pathological features of patients with chronic sinusitis and nasal polyps following endoscopic surgery. Exp Ther Med. 2013 Jul. 6(1):167-171. [QxMD MEDLINE Link]. [Full Text].

10. Kingdom TT, Orlandi RR. Image-guided surgery of the sinuses: current technology and applications. Otolaryngol Clin North Am. 2004 Apr. 37(2):381-400. [QxMD MEDLINE Link].

11. Mendelsohn D, Jeremic G, Wright E, Rotenberg E. Revision Rates After Endoscopic Sinus Surgery: A Recurrence Analysis. Ann Otol Rhinol Laryngol. March 2011. 120(3):162-166.

12. Mimari C, Radulesco T, Penicaud M, Dessi P, Michel J. Surgical management of chronic rhinosinusitis with nasal polyps under local anaesthesia: indications and results. Acta Otorhinolaryngol Ital. 2023 Feb. 43 (1):42-8. [QxMD MEDLINE Link]. [Full Text].

13. Dadgarnia M, Rahmani A, Baradaranfar M, et al. The relationship between endoscopic and radiologic findings and olfactory status of patients with chronic rhinosinusitis with nasal polyps before and after the endoscopic sinus surgery. Eur Arch Otorhinolaryngol. 2018 Nov 27. [QxMD MEDLINE Link].

14. Kumar N, Sindwani R. Bipolar microdebrider may reduce intraoperative blood loss and operating time during nasal polyp surgery. Ear Nose Throat J. 2012 Aug. 91(8):336-44. [QxMD MEDLINE Link].

15. Bassiouni A, Wormald PJ. Role of frontal sinus surgery in nasal polyp recurrence. Laryngoscope. 2013 Jan. 123(1):36-41. [QxMD MEDLINE Link].

16. Vento SI, Blomgren K, Hytönen M, Simola M, Malmberg H. Prevention of relapses of nasal polyposis with intranasal triamcinolone acetonide after polyp surgery: a prospective double-blind, placebo-controlled, randomised study with a 9-month follow-up. Clin Otolaryngol. 2012 Apr. 37(2):117-23. [QxMD MEDLINE Link].

17. Arancibia C, Langdon C, Mullol J, Alobid I. Twelve-year long-term postoperative outcomes in patients with chronic rhinosinusitis with nasal polyps. Rhinology. 2022 Aug 1. 60 (4):261-9. [QxMD MEDLINE Link].

18. Nguyen DT, Felix-Ravelo M, Arous F, Nguyen-Thi PL, Jankowski R. Facial pain/headache before and after surgery in patients with nasal polyposis. Acta Otolaryngol. 2015 Jun 25. 1-6. [QxMD MEDLINE Link].

19. Kilty SJ, Lasso A, Mfuna-Endam L, Desrosiers MY. Case-control study of endoscopic polypectomy in clinic (EPIC) versus endoscopic sinus surgery for chronic rhinosinusitis with polyps. Rhinology. 2018 Jun 1. 56 (2):155-7. [QxMD MEDLINE Link].

20. Brescia G, Marioni G, Franchella S, et al. A prospective investigation of predictive parameters for post-surgical recurrences in sinonasal polyposis. Eur Arch Otorhinolaryngol. 2015 Mar 13. [QxMD MEDLINE Link].

21. Hopkins C, Lund V. Does time from previous surgery predict subsequent treatment failure in Chronic Rhinosinusitis with Nasal Polyps?. Rhinology. 2021 Jun 1. 59 (3):277-83. [QxMD MEDLINE Link].

Andrew T Cheng, MD Clinical Assistant Professor, Department of Otolaryngology-Head & Neck Surgery, New York Medical College

Andrew T Cheng, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, Medical Society of the State of New York

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Nader Sadeghi, MD, FRCSC Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, McGill University Faculty of Medicine; Chief Otolaryngologist, MUHC; Director, McGill Head and Neck Cancer Program, Royal Victoria Hospital, Canada

Nader Sadeghi, MD, FRCSC is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society, American Thyroid Association, Royal College of Physicians and Surgeons of Canada

Disclosure: Serve(d) as a speaker or a member of a speakers bureau for: Merck.

Arlen D Meyers, MD, MBA Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cerescan; Ryte; Neosoma; MI10<br/>Received income in an amount equal to or greater than $250 from: Neosoma; Cyberionix (CYBX)<br/>Received ownership interest from Cerescan for consulting for: Neosoma, MI10.

Eric J Moore, MD, FACS Residency Director, Associate Professor, Department of Otorhinolaryngology-Head and Neck Surgery, Mayo Graduate School of Medicine

Eric J Moore, MD, FACS is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Head and Neck Society, American Academy of Otolaryngology-Head and Neck Surgery, American Cleft Palate-Craniofacial Association

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article